The Latin America, Middle East and Africa Antimicrobial Susceptibility Testing Market would witness market growth of 9.5% CAGR during the forecast period (2022-2028).
Antibacterial medications have a crucial role in preventing infectious diseases; nonetheless, drug abuse and overuse have contributed to the emergence of antibiotic resistance. Furthermore, it is difficult to limit the spread of infectious diseases when there is a delay in detecting hazardous bacteria. This places pressure on the key actors to produce accurate and effective test kits to treat patients more effectively.
AST also aids in the discovery of new antimicrobial medications by determining the susceptibility of existing or newly developed antimicrobial treatments against infection-causing microbes. While AST is a significant tool, it should not be the only consideration considered when establishing the optimal treatment approach for a patient. When picking the most appropriate antibiotic, examining the patient's allergies, kidney function, other medications, and general condition is necessary. AMR is a developing problem caused by microorganisms like bacteria, fungi, viruses, and parasites that have gained the ability to withstand the effects of medications such as antivirals, antibiotics, and antifungals.
In the United Arab Emirates (UAE), the national action plan (NAP) on antimicrobial resistance (AMR) was developed to explain the current national responses to AMR in the sectors of environmental protection, food safety, and human & animal health. In addition, technical subcommittees led the development and implementation of strategies and actions in certain domains, such as antimicrobial stewardship programs (ASP), surveillance, antimicrobial resistance (AMR) prevention & control, and infection prevention & control (IPC). These activities will be conducted along with other relevant ministries, authorities, organizations, research institutes, and comparison laboratories. As a result, AMR testing is gaining speed in the region, fueling the expansion of the antimicrobial resistance diagnostic market.
The Brazil market dominated the LAMEA Antimicrobial Susceptibility Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $88.8 million by 2028. The Argentina market is experiencing a CAGR of 10% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 9.2% during (2022 - 2028).
Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development and Epidemiology & Others. Based on Method, the market is segmented into Automated Susceptibility Testing Instruments, Disk Diffusion, Etest Method, Agar Diffusion, and Genotyping Method. Based on Type, the market is segmented into Antibacterial, Antifungal, Antiparasitic, and Others. Based on End User, the market is segmented into Hospitals & Diagnostic centers, Pharmaceutical & Biotechnology Companies, Research & Academic Institutes, and Clinical Research Organizations. Based on Product, the market is segmented into Automated Laboratory Instruments, Manual Laboratory Instruments, Culture & Growth Media and Consumables. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide Antimicrobial Susceptibility Testing Market is Projected to reach USD 4.9 Billion by 2028, at a CAGR of 5.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMérieux S.A., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, Bruker Corporation, Accelerate Diagnostics, Inc., HiMedia Laboratories Pvt. Ltd., and F. Hoffmann-La Roche Ltd.
By Application
By Method
By Type
By End User
By Product
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
